CSPC PHARMACEUT.GR. ADR4 Cash Flow Reinvestment Rate
CSPC PHARMACEUT.GR. ADR4 cash flow reinvestment rate. CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Cash Flow Reinvestment Rate of 0.74x as of December 2025, reinvesting €4.33 Billion (capex €2.28 Billion plus investments €-2.05 Billion) from operating cash flow of €5.83 Billion. Explore CVGU cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Cash flow reinvestment rate of CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025. Historical reinvestment intensity for CSPC PHARMACEUT.GR. ADR4 across 5 annual periods. Explore CSPC PHARMACEUT.GR. ADR4 capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
CSPC PHARMACEUT.GR. ADR4 Cash Flow Reinvestment Rate by Year (2021–2025)
CSPC PHARMACEUT.GR. ADR4 cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for CSPC PHARMACEUT.GR. ADR4. For the full cash flow conversion analysis, see CSPC PHARMACEUT.GR. ADR4 (CVGU) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | €4.33 Billion | €5.83 Billion | €2.28 Billion | ▼ -18.3% |
| 2024 | 0.91x | €4.12 Billion | €4.53 Billion | €2.68 Billion | ▼ -9.1% |
| 2023 | 1.00x | €4.18 Billion | €4.18 Billion | €1.89 Billion | ▲ +15.8% |
| 2022 | 0.86x | €6.59 Billion | €7.63 Billion | €2.72 Billion | ▲ +114.8% |
| 2021 | 0.40x | €1.86 Billion | €4.64 Billion | €1.76 Billion | — |